aTyr Pharma, Inc. (ATYR)
NASDAQ·Healthcare·Biotechnology
$0.13
+1.25%
Mkt Cap $16.67M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$5.13
Range $1.00 – $17.00
Implied Upside
+3976.3%
Consensus $5.13 vs current $0.13
NASDAQ·Healthcare·Biotechnology
$0.13
+1.25%
Mkt Cap $16.67M
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$5.13
Range $1.00 – $17.00
+3976.3%
Consensus $5.13 vs current $0.13